Clinical Trial Update: Study of Combination Ruxolitinib and Decitabine Treatment for Accelerated Phase MPN or Post-MPN AML [Phase 1, Phase 2]

View source ↗

Summary

A trial evaluating the combination of ruxolitinib and decitabine in accelerated phase myeloproliferative neoplasms or post-MPN acute myeloid leukemia has comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myeloproliferative Neoplasms

Drugs mentioned

• Decitabine (Decitabine)
• Ruxolitinib (ruxolitinib)

Snippet

Sponsor: John Mascarenhas | Conditions: Myeloproliferative Neoplasms | Phase 1, Phase 2 | Status: COMPLETED